Mises Wire
Author:
Gilbert Berdine, MD
Online Publish Date:
Enter “outrageous drug prices” into Google and you will receive plenty of examples. As reported here , Marathon Pharmaceuticals planned to charge $89,000 per year for its Emflaza brand of the corticosteroid deflazacort. Deflazacort was introduced in 1969 and is available outside the U.S. for less than $2 per tablet. US patients with muscular